ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

Penn Engineers have developed a new way to use AI to solve inverse partial differential equations (PDEs), a particularly ...

Explore 25 AI Facts That Feels Illegal To Know. Uncover unsettling truths about AI's hidden powers: predictive policing, ...

We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...

Najat Khan, CEO, opened by stating that Recursion is at an important inflection point, harnessing its integrated AI-driven platform to "translate insights into evidence; evidence that this platform, ...

Health Discovery Corp. company and executive profile by Barron's. View the latest HDVY company infomation and executive bios.

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, and I'm delighted to welcome you to our Earnings Call this morning. We're going to go ahead and get started. Perfect. So, of ...

Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 ...

Interactive C-based application for solving and visualizing the Tower of Hanoi problem. Features recursive and iterative algorithms with graphical representation using the Raylib library, and ...